Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

11.11
-0.0650-0.58%
Volume:913.74K
Turnover:10.08M
Market Cap:7.92B
PE:-71.34
High:11.21
Open:11.16
Low:10.91
Close:11.17
Loading ...

News Flash: Analysts Just Made A Captivating Upgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) Forecasts

Simply Wall St.
·
12 Feb

Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Feb

Roivant Sciences price target lowered to $12 from $13 at BofA

TIPRANKS
·
11 Feb

Roivant Sciences (ROIV) Receives a Hold from Bank of America Securities

TIPRANKS
·
11 Feb

Stock Track | Roivant Sciences Soars 5.51% Pre-Market on Promising Pipeline and Earnings Surprise

Stock Track
·
10 Feb

Roivant Sciences Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
10 Feb

Sector Update: Health Care Stocks Flat to Edging Higher Pre-Bell Monday

MT Newswires Live
·
10 Feb

Roivant Sciences Fiscal Q3 Earnings, Revenue Fall

MT Newswires Live
·
10 Feb

Roivant Sciences Q3 Adj $(0.20) Beats $(0.28) Estimate, Sales $9.02M Miss $15.99M Estimate

Benzinga
·
10 Feb

BRIEF-Roivant Sciences Q3 EPS USD 0.23

Reuters
·
10 Feb

Roivant Sciences Q3 Net Income USD 118.075 Million

THOMSON REUTERS
·
10 Feb

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update

THOMSON REUTERS
·
10 Feb

Press Release: Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update

Dow Jones
·
10 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Feb

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025

THOMSON REUTERS
·
30 Jan

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025

GlobeNewswire
·
30 Jan

Bank of America Securities Reaffirms Their Hold Rating on Roivant Sciences (ROIV)

TIPRANKS
·
14 Jan

Roivant Sciences Ltd : Guggenheim Cuts Target Price to $15 From $16

THOMSON REUTERS
·
03 Jan

Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing

Insider Monkey
·
02 Jan

Roivant Sciences (ROIV) Receives a Buy from Leerink Partners

TIPRANKS
·
18 Dec 2024